CXCL17 and pancreatic intraductal papillary-mucinous neoplasm: In premalignant intraductal papillary mucinous neoplasm, CXCL17 induces DC accumulation at the tumor site, which promotes tumor cell susceptibility to cytotoxic T cell-mediated cytolysis [20].